Pathology and Data Management

$215,854P50FY2015CANIH

University Of Tx Md Anderson Can Ctr, Houston TX

Investigators

Bogdan A Czerniakcontact Randall E Millikan

Linked publications & trials

Paper 38676926 Paper 37442564 Paper 37246493 Paper 36404232 Paper 35770498 Paper 34920986 Paper 34184926 Paper 33935020 Paper 33881933 Paper 33783950 Paper 33563539 Paper 33502236 Paper 33258948 Paper 32546765 Paper 32253420 Paper 32122956 Paper 31757304 Paper 31067463 Paper 30415317 Paper 29955780 Paper 29763719 Paper 29660813 Paper 29529165 Paper 29428551 Paper 29235103 Paper 29179475 Paper 29174465 Paper 29088836 Paper 28988769 Paper 28851898 Paper 28834453 Paper 28827100 Paper 28826932 Paper 28823575 Paper 28753816 Paper 28365159 Paper 28149933 Paper 28102366 Paper 28018013 Paper 27845906 Paper 27825764 Paper 27818773 Paper 27797838 Paper 27612592 Paper 27499906 Paper 27494900 Paper 27480598 Paper 27387678 Paper 27291797 Paper 26988609 Paper 26922408 Paper 26907529 Paper 26732427 Paper 26515115 Paper 26464424 Paper 26364859 Paper 26343003 Paper 26280620 Paper 26173102 Paper 26119560 Paper 26032953 Paper 25896234 Paper 25851338 Paper 25443274 Paper 25416716 Paper 25320178 Paper 25219851 Paper 25199718 Paper 25027329 Paper 24931270 Paper 24525232 Paper 24503570 Paper 24449888 Paper 24391818 Paper 24163127 Paper 24121789 Paper 24053608 Paper 23946494 Paper 23911605 Paper 23874968 Paper 23657946 Paper 23553206 Paper 23529717 Paper 23507396 Paper 23500642 Paper 23468956 Paper 23322153 Paper 23284679 Paper 23272234 Paper 23251617 Paper 23239884 Paper 23040072 Paper 22914978 Paper 22895070 Paper 22879988 Paper 22863868 Paper 22742565 Paper 22701660 Paper 22586063 Paper 22583635

Abstract

The task of this Core is to provide well characterized, high-quality human-derived biospecimens required by the projects and to insure that longitudinal, structured, clinical information related to treatment and outcome is collected from the patient donors of those specimens. The primary substrate for these genetic characterization projects is a unique resource consisting of whole-organ maps that will provide histologic characterization and sufficient DNA and RNA to allow multiple experiments to be done on the same samples. This provides an unprecedented opportunity to cross-validate biologic insights coming from these different experimental platforms, and should provide, by far, the most complete view of urothelial carcinogenesis and progression ever realized. This Core will serve as a model for addressing the difficult problems of cross investigator and cross-institutional data exchange, issues of significant interest for the broader context of Texas cancer research. This Core will provide a web-based portal that will allow all investigators to browse and query the contents of the biorepository, de-identified clinical data, and translational research resources such as Standard Operating Procedures, reagent details, and primary datasets. The specific aims for the core are as follows: Specific Aim 1: Provide pathologic review of all tissues. Specific Aim 2: Maintain a urothelial biospecimen repository, Specific Aim 3: Provide professional and technical services for the preparation and quality control of molecular analytes from the biospecimen repository. Specific Aim 4: Abstract clinical information for all patients providing biospecimens. Specific Aim 5: Capture longitudinal clinical follow-up on all patients providing biospecimens. Specific Aim 6: Assure that all information related to the SPORE Project is exchangeable. Specific Aim 7: Provide all SPORE Investigators with a common portal for access to Project data, including support for ad hoc query across projects and domains

View original record on NIH RePORTER →